|
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
In virgin female mice, pro-lactin overexpression under control of a mammary selective nonhormonally responsive promoter, neu-related lipocalin, results in estrogen receptor alpha (ERalpha)-positive and ERalpha-negative adenocarcinomas.
|
16565509 |
2006 |
|
Adenocarcinoma
|
0.400 |
PosttranslationalModification
|
group |
BEFREE |
Comparison of methylation in adenocarcinoma cell lines and tumors versus non-tumor lung tissue showed methylation of ESR1, PGR1 and RASSF1 to be significantly elevated in adenocarcinoma, with RASSF1 being most significant (P=0.0002).
|
15639718 |
2005 |
|
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
CTD_human |
Comparison of methylation in adenocarcinoma cell lines and tumors versus non-tumor lung tissue showed methylation of ESR1, PGR1 and RASSF1 to be significantly elevated in adenocarcinoma, with RASSF1 being most significant (P=0.0002).
|
15639718 |
2005 |
|
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
|
16271083 |
2005 |
|
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Immunohistochemical evaluation of androgen receptor (AR), estrogen receptor-alpha (ER-alpha), estrogen receptor-beta (ER-beta), and progesterone receptor (PR) was carried out in prostate needle biopsies obtained before and after radiotherapy from 60 patients with adenocarcinoma.
|
15900599 |
2005 |
|
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
In Borrmann IV gastric carcinoma ER positive rate was greater than that in other pathologic types, and in poorly differentiated adenocarcinoma and signet ring cell carcinoma the positive rates were greater than those in other histological types of both males and females (P<0.05).
|
12679906 |
2003 |
|
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
[Profile of estrogen receptor alpha isoforms in endometrial adenocarcinoma].
|
14674143 |
2003 |
|
Adenocarcinoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Compared to age-matched postmenopausal controls, the ER-alpha/beta ratio was reduced in both grade I adenocarcinoma and MMMT specimens (3.3 and 6.8, respectively), due to a selective loss of ER-alpha.
|
11687977 |
2001 |
|
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In addition, intracellular hK4 levels, as detected on Western blot analysis, were induced by 100 nM estrogen treatment of the estrogen receptor positive ovarian carcinoma cell line OVCAR-3, >8-24 h. Our results show that the level of KLK4 expression and expression of KLK4 mRNA variants are associated with progression of ovarian cancer, particularly late stage SER adenocarcinomas.
|
11489814 |
2001 |
|
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Human adenocarcinoma cells that are either estrogen-receptor positive (such as MCF-7) or estrogen-receptor negative (such as MDA-MB-468) were used as our model system.
|
9848511 |
1998 |
|
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
The results of this study show that bcl-2 is relatively highly expressed in proliferative (n = 11) and hyperplastic (n = 18) endometrium, with respective mean staining scores of 3.59 and 3.47 (scale, 0-4), but is significantly (P < 0.001) down-regulated in atypical hyperplasia (n = 11; score, 0.82), and adenocarcinoma (n = 34; score, 0.86). bcl-2 expression did not correlate with stage, grade, estrogen-receptor, or progesterone-receptor expression.
|
8729985 |
1996 |
|
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
We have introduced the human estrogen receptor (ER) gene into HeLa cells, a human adenocarcinoma cell line of uterine origin, by infection.
|
1682189 |
1991 |